Allergan plc, a leading global pharmaceutical company, announced that it has successfully completed the acquisition of Kythera Biopharmaceuticals, Inc., a company focused on the discovery, development and commercialization of novel

This content is restricted to site members. If you are an existing user, please log in. New users may register below.

Existing Users Log In